FDA ANDA · ANDA215701
SUGAMMADEX SODIUM
Sponsor: SHANDONG
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA215701
TYPE
ANDA
ORIGINAL APPROVAL
2026-10-06
LATEST ACTION
2026-10-06
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
SUGAMMADEX SODIUMPrescription
SUGAMMADEX SODIUM EQ 200MG BASE/2ML (EQ 100MG BASE/ML) · SOLUTION · INTRAVENOUS
SUGAMMADEX SODIUMPrescription
SUGAMMADEX SODIUM EQ 500MG BASE/5ML (EQ 100MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2026-10-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →